The independent source for health policy research, polling, and news.
61-80 of 238 results
杨贵妃传媒視頻 Health News and California Healthline staff made the rounds on national and local media this week to discuss topical stories. Here鈥檚 a collection of their appearances.
The FDA told Amgen to test whether a quarter-dose of its lung cancer drug worked as well as the amount recommended on the product label. It did and with fewer side effects. But Amgen is sticking to the higher dose 鈥 which earns it an additional $180,000 a year per patient.
People in their prime working years living in rural America are 43% more likely to die of natural causes, like diseases, than their urban counterparts, a disparity that grew rapidly in recent decades, according to a new federal report.
The FDA and some oncologists have resisted efforts to require a quick, cheap gene test that could prevent thousands of deaths from a bad reaction to a common cancer drug.
A state policy to extend Medi-Cal to qualified Californians without legal residency is running up against a federal requirement to resume eligibility checks. The redetermination process is causing many Latinos, who make up a majority of Medi-Cal beneficiaries, to be disenrolled.
A recent report finds half of America鈥檚 rural hospitals are losing money, and many are struggling to stay open. Researchers and advocates worry the hospitals鈥 financial spiral will have immediate and long-term health effects on their communities.
The Environmental Protection Agency is tightening regulation of ethylene oxide, a carcinogenic gas used to sterilize medical devices. The agency is trying to balance the interests of the health care industry supply chain with those of communities where the gas creates airborne health risks.
A restructuring of the Medicare drug benefit has wiped out big drug bills for people who need expensive medicines. But the legal battle over drug negotiations means uncertainty over long-term savings.
After a decade of work, a Kentucky program launched to diagnose lung cancer earlier is beginning to change the prognosis for residents by catching tumors when they鈥檙e more treatable.
The FDA鈥檚 recent notice that it would move to ban formaldehyde in hair-straightening products comes more than a decade after researchers raised alarms about health risks. Scientists say a ban would still leave many dangerous chemicals in hair straighteners.
Casinos in several states are fighting efforts to ban smoking, and trying to roll back existing anti-smoking laws. One planned facility even moved outside a city鈥檚 limits because of voter-approved smoking restrictions.
Artificial intelligence software to aid radiologists in detecting problems or diagnosing cancer has been moving rapidly into clinical use, where it shows great promise. But it鈥檚 a turnoff for some patients asked to pay out-of-pocket for technology that鈥檚 not quite ready for prime time.
Delaying cancer treatment can be deadly 鈥 which makes the roadblock-riddled process that health insurers use to approve or deny care particularly daunting for oncology patients.
The popular actress and author, who died this week, also can be remembered as a progenitor of selling dubious medical information to a trusting public.
A breast cancer patient who received similar treatments in two states saw significant differences in cost, illuminating how care in remote areas can come with a stiffer price tag.
Federal research linking 鈥渇orever chemicals鈥 to testicular cancer confirms what U.S. military personnel long suspected. But as they seek testing for PFAS exposure, many wonder what to do with the results. There鈥檚 no medical treatment yet.
Mississippi has among the highest cervical cancer mortality rates in the U.S. When low-income women can't afford regular preventive care, much less gynecological visits, this highly preventable and treatable cancer becomes a killer.
The first of a new wave of cancer-detection blood tests likely saved Gilbert Milam Jr.鈥檚 life. But many cancer researchers, wary of overtesting, argue it鈥檚 premature to prescribe the Galleri test widely.
The military first documented health concerns surrounding chemicals known as PFAS decades ago yet has continued to use firefighting foam made with them. Despite scores of lawsuits by its personnel and high rates of testicular cancer among troops, it has been slow to investigate a connection.
Social and economic pressures have long compelled Black girls and women to straighten their hair. But mounting evidence shows chemical straighteners 鈥 products with little regulatory oversight 鈥 may pose cancer and other health risks.
漏 2026 KFF